Advertisement
Research Article Free access | 10.1172/JCI113616
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by De Feo, P. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Gallai, V. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Mazzotta, G. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Crispino, G. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Torlone, E. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Perriello, G. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Ventura, M. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Santeusanio, F. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Brunetti, P. in: JCI | PubMed | Google Scholar
Istituto di Patologia Medica, Unviersity of Perugia, Italy.
Find articles by Bolli, G. in: JCI | PubMed | Google Scholar
Published August 1, 1988 - More info
To establish the glycemic threshold for onset of neuroglycopenia (impaired cognitive function, measured by the latency of the P300 wave), activation of hormonal counterregulation and hypoglycemic symptoms, 12 normal subjects were studied either under conditions of insulin-induced, glucose-controlled plasma glucose decrements, or during maintenance of euglycemia. A decrement in plasma glucose concentration from 88 +/- 3 to 80 +/- 1 mg/dl for 150 min did not result in changes in the latency of the P300 wave nor in an activation of counterregulatory hormonal response. In contrast, a greater decrement in plasma glucose concentration from 87 +/- 3 to 72 +/- 1 mg/dl for 120 min caused an increase in the latency of the P300 wave (from 301 +/- 12 to 348 +/- 20 ms, P less than 0.01), a subsequent increase in all counterregulatory hormones but no hypoglycemic symptoms. Finally, when plasma glucose concentration was decreased in a stepwise manner from 88 +/- 2 to 50 +/- 1 mg/dl within 75 min, the increase in the latency of the P300 wave was correlated with the corresponding plasma glucose concentration (r = -0.76, P less than 0.001). The glycemic threshold for hypoglycemic symptoms was 49 +/- 2 mg/dl. Thus, in normal man the glycemic threshold for neuroglycopenia (72 +/- 1 mg/dl) is greater than currently thought; the hormonal counterregulation follows the onset of neuroglycopenia; the hypoglycemic symptoms are a late indicator of advanced neuroglycopenia.